Empyrean Capital Partners, LP

Position in INBX — Inhibrx Biosciences, Inc.

CIK 1317195 LOS ANGELES, CA

Position in INBX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,842,500

New position

Shares Held

30,000

first reported quarter

Ownership

0.204%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#40

of 161 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Empyrean Capital Partners, LP holds $18,125,072 across 3 Biotechnology names. INBX ranks #2 (15.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	75,400	$14,120,912
2	INBX	Inhibrx Biosciences, Inc. This page	30,000	$2,842,500
3	VIR	Vir Biotechnology, Inc.	114,000	$1,161,660

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,842,500	30,000	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.